MetaCap

Altimmune Statistics

NASDAQ: ALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.33-0.08 (-5.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Altimmune by the numbers

Altimmune has a market capitalization of $258.8 million based on 194.59M shares outstanding. With trailing EPS of $-0.71, Altimmune is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 44.4% below its 50-day average and 56.1% below its 200-day average.

Average daily trading volume is 3.91M shares, or about $5.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ALT valuation vs. peer median

ALT compared with the median of 8 peer companies
MetricALTPeer medianDifference
Market cap$258.80M$259.14M-0%
Avg. volume3.91M423.72K+822%

Peer median across 8 companies: PRLD, EBS, VCRE, QTTB, TTRX, GALT, LFCR, RLMD.

Valuation

Market cap
$258.80M
Price / sales (latest FY)
6,312.29
EPS (TTM)
$-0.71

Price and trading

Previous close
1.41
Open
1.37
Day range
1.32 – 1.46
52-week range
1.32 – 6.44
52-week change
-72.35%
Beta
—
Volume
4.02M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
258.80M
Forward Pe
-1.87
Eps
-0.71
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.44
Week52 Low
1.32
Avg Volume
3.91M
Shares Outstanding
194.59M
Ma50
2.39
Ma200
3.03
Earnings Date
Nov 12, 2026
Pct From52w High
-79.35%
Pct From52w Low
0.76%

Related